RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

NCT00364689 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Difficult to recruit participants

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin
DRUG: Lactulose
OTHER: Placebo

Sponsor

University of Miami

Collaborators

[object Object]